Cefradine

头孢拉定

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameCefradine
Drug Alias NameCephradine先锋Ⅵ先锋瑞丁CefradinumCefradina +[18] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Huajin Pharmaceutcial Co Ltd
Inactive CompaniesErsana Inc Sub Er Squibb And SonsBristol-Myers Squibb Company
Active IndicationsBacterial Infections
Inactive IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections

Other Information

ATC CodeJ01DB09
Related LinksWikipediaDrugBankKEGG